Clinical trial
TNF Alpha in Refractory Asthma
NCT00276029 · University Hospitals, Leicester, Other · Completed
Key facts
| NCT number | NCT00276029 |
|---|---|
| Title | TNF Alpha in Refractory Asthma |
| Official title | The Efficacy of a Soluble Ligand Binding Tumour Necrosis Factor Receptor, Etanercept, in Severe, Steroid Dependant Asthma: a Randomised Controlled Study |
| Lead sponsor | University Hospitals, Leicester, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 10 |
| Start date | Dec 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Jan 12, 2006 |
| Last update posted | May 4, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: